Session length

1 / 20

Renal cell carcinoma can cause polycythemia through ectopic erythropoietin production. Which hematologic change does this cause?

Polycythemia due to ectopic erythropoietin production

Ectopic erythropoietin production by a renal cell carcinoma stimulates red blood cell production in the bone marrow, leading to polycythemia. EPO acts on erythroid precursors to boost erythropoiesis, so tumor-derived EPO raises the red cell mass and hemoglobin/hematocrit levels, independent of oxygen needs. This is a classic paraneoplastic syndrome of RCC. The other options describe scenarios with reduced red cells or other cell lines, which don’t fit this mechanism: decreased EPO causing anemia, or changes in platelets or white cells are not the typical RCC paraneoplastic presentation.

Anemia due to decreased erythropoietin production

Thrombocytopenia due to platelet consumption

Leukopenia due to marrow suppression

Next question

Find the option that is right for you!

All options are one-time payments.

$12.50

30 day premium pass

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
$30.00 $87.50 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $87.50 usd value for $30.00! You save $57.50!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$12.50 $18.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy